Themis Medicare (Themis) has entered into a License and Supply
Agreement with Novartis India (Novartis) on March 26, 2013. As per
agreement, Themis has agreed to manufacture and supply Diclofenac
topical gel formulated using unique TPM transdermal drugs delivery
system in finished dosage pharmaceutical form on certain commercial
terms and conditions. Novartis has agreed to purchase the same.Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.
No comments:
Post a Comment